Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.

What symbol and exchange does Exagen shares trade?

Exagen trades on the NASDAQ stock market under the symbol XGN.

What is Exagen stock price doing today?

As of November 3, 2026, XGN stock price declined to $8.34 with 92,640 million shares trading.

What is Exagen's Beta?

XGN has a beta of 2.84, meaning it tends to be more sensitive to market movements. XGN has a correlation of 0.15 to the broad based SPY ETF.

How much is Exagen worth?

XGN has a market cap of $201.35 million. This is considered a Small Cap stock.

How much money does Exagen make?

Last quarter Exagen reported $20 million in Revenue and -$.13 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.06.

What is the highest and lowest price Exagen traded in the last 3 year period?

In the last 3 years, XGN traded as high as $12.23 and as low as $1.30.

What are the top ETFs holding Exagen?

The top ETF exchange traded funds that XGN belongs to (by Net Assets): VTI, VXF, IWC, BUSM, QQQS.

Is Exagen (XGN) a good investment?

XGN has underperformed the market in the last year with a return of -29.5%, while SPY returned +11.5%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in XGN shares. However, XGN has outperformed the market in the last 3 month and 2 week periods, returning +78.2% and +12.6%, while SPY returned -0.2% and -1.9%, respectively. This indicates XGN has been having a stronger performance recently.

What are the support and resistance levels for Exagen (XGN)?

XGN support price is $8.00 and resistance is $8.78 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XGN shares will trade within this expected range on the day.